Gallacher Capital Management LLC

Position in GSK — GSK plc

CIK 1960749 LONE TREE, CO

Position in GSK

as of Jun 30, 2026 · filed Jul 17, 2026 Compact

Position Value

$435,715

-$457,424 QoQ

Shares Held

8,312

-48.6% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.43%

of 13F equity value

Holder Rank

#502

of 1,033 holders

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Gallacher Capital Management LLC holds $3,790,927 across 9 Drug Manufacturers - General names. GSK ranks #5 (11.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	532	$638,096
2	NVS	Novartis AG	3,514	$550,714
3	NVO	Novo Nordisk A S	11,461	$549,440
4	JNJ	Johnson & Johnson	1,733	$440,130
5	GSK	GSK plc This page	8,312	$435,715
6	AZN	Astrazeneca PLC	2,120	$401,994
7	AMGN	Amgen Inc	797	$288,609
8	SNY	Sanofi	6,375	$271,957

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$435,715	8,312	-48.6%	Shares	Sole	2026-07-17
2026-03-31	$893,139	16,183	+2.6%	Shares	Sole	2026-05-06
2025-12-31	$773,311	15,769	+0.3%	Shares	Sole	2026-02-03
2025-09-30	$678,863	15,729	+25.1%	Shares	Sole	2025-11-05
2025-06-30	$482,803	12,573	+2.9%	Shares	Sole	2025-07-08
2025-03-31	$473,557	12,224	+8.4%	Shares	Sole	2025-05-05
2024-12-31	$381,523	11,281	+1.4%	Shares	Sole	2025-02-10
2024-09-30	$454,585	11,120	+3.3%	Shares	Sole	2024-11-12
2024-06-30	$414,414	10,764	+5.1%	Shares	Sole	2024-08-06
2024-03-31	$438,903	10,238	+2.2%	Shares	Sole	2024-05-06
2023-12-31	$371,155	10,015	+0.8%	Shares	Sole	2024-02-06
2023-09-30	$360,071	9,933	+1.8%	Shares	Sole	2023-11-13
2023-06-30	$347,810	9,759	+6.4%	Shares	Sole	2023-08-11
2023-03-31	$326,482	9,176	+18.0%	Shares	Sole	2023-05-12
2022-12-31	$273,283	7,777	—	Shares	Sole	2023-01-17
No filing history on record for this holder in this stock.